PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER (calcium chloride) · VANTIVE US HLTHCARE
This solution serves as a source of water and essential electrolytes for both adult and pediatric patients. It helps patients maintain proper fluid balance and supports the regulation of acid-base levels in the body. Healthcare providers use this to ensure patients receive necessary minerals like sodium, potassium, and calcium required for various physiological processes.
How PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER Works
This injection works by delivering key ions that regulate bodily functions, such as sodium for fluid distribution and potassium for nerve conduction and heart muscle contraction. It also provides calcium, which is necessary for blood clotting and cardiac performance, and chloride to help maintain the body's acid-base equilibrium.
Details
- Status
- Prescription
- First Approved
- 2006-10-25
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
Companies
PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER Approval History
What PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER Treats
2 indicationsPRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER is approved for 2 conditions since its original approval in 2006. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Electrolyte deficiency
- Fluid deficiency
Drugs Similar to PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER
3 of 18FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
7 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT07550413 | 20042026 | Ph 2 | not yet recruiting | Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section |
| NCT03772990 ICARUS | 21/2019 | Ph 4 | completed | Calcium Administration in Cardiac Surgery |
| NCT05027048 CALBLOC results posted | 62206 MRTG-02-15-2022-Ansari, YIG-2020 | Ph 3 | completed | Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery |
| NCT04153435 COCA results posted | 00002 2019-003387-46 | Ph 2 | completed | Calcium for Out-of-Hospital Cardiac Arrest |
| NCT03867383 results posted | 43076 | Ph 1, Ph 2 | completed | Calcium Chloride for Prevention of Uterine Atony During Cesarean |
| NCT01941914 | AA1310 | Ph 1 | completed | Calcium Electroporation for the Treatment of Keloids |
| NCT00955266 results posted | 2009-P-000052 | Ph 4 | terminated | A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER FDA Label Details
Indications & Usage
FDA Label (PDF)Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients. Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients.
Track PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.